Literature DB >> 20053537

Avoidant personality disorder symptoms in first-degree relatives of schizophrenia patients predict performance on neurocognitive measures: the UCLA family study.

D L Fogelson1, R A Asarnow, C A Sugar, K L Subotnik, K C Jacobson, M C Neale, K S Kendler, H Kuppinger, K H Nuechterlein.   

Abstract

Whether avoidant personality disorder symptoms are related to neurocognitive impairments that aggregate in relatives of schizophrenics is unknown. We report the relationship between avoidant personality disorder symptoms and neurocognitive performance in the first-degree relatives of probands with schizophrenia. 367 first-degree relatives of probands with schizophrenia and 245 relatives of community controls were interviewed for the presence of avoidant personality symptoms and symptoms of paranoid and schizotypal personality disorders and administered neurocognitive measures. Relationships between neurocognitive measures and avoidant symptoms were analyzed using linear mixed models. Avoidant dimensional scores predicted performance on the span of apprehension (SPAN), 3-7 Continuous Performance Test (3-7 CPT), and Trail Making Test (TMT-B) in schizophrenia relatives. These relationships remained significant on the SPAN even after adjustment for paranoid or schizotypal dimensional scores and on the TMT-B after adjustment for paranoid dimensional scores. Moreover, in a second set of analyses comparing schizophrenia relatives to controls there were significant or trending differences in the degree of the relationship between avoidant symptoms and each of these neurocognitive measures even after adjustments for paranoid and schizotypal dimensional scores. The substantial correlation between avoidant and schizotypal symptoms suggests that these personality disorders are not independent. Avoidant and in some cases schizotypal dimensional scores are significant predictors of variability in these neurocognitive measures. In all analyses, higher levels of avoidant symptoms were associated with worse performance on the neurocognitive measures in relatives of schizophrenia probands. These results support the hypothesis that avoidant personality disorder may be a schizophrenia spectrum phenotype. (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20053537      PMCID: PMC2888850          DOI: 10.1016/j.schres.2009.12.004

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  30 in total

1.  The family history method using diagnostic criteria. Reliability and validity.

Authors:  N C Andreasen; J Endicott; R L Spitzer; G Winokur
Journal:  Arch Gen Psychiatry       Date:  1977-10

2.  National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity.

Authors:  L N Robins; J E Helzer; J Croughan; K S Ratcliff
Journal:  Arch Gen Psychiatry       Date:  1981-04

3.  Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: the UCLA family study.

Authors:  R F Asarnow; K H Nuechterlein; D Fogelson; K L Subotnik; D A Payne; A T Russell; J Asamen; H Kuppinger; K S Kendler
Journal:  Arch Gen Psychiatry       Date:  2001-06

4.  The structure of schizotypy: relationships between neurocognitive and personality disorder features in relatives of schizophrenic patients in the UCLA Family Study.

Authors:  Keith H Nuechterlein; Robert F Asarnow; Kenneth L Subotnik; David L Fogelson; Diana L Payne; Kenneth S Kendler; Michael C Neale; Kristen C Jacobson; Jim Mintz
Journal:  Schizophr Res       Date:  2002-03-01       Impact factor: 4.939

5.  Span of apprehension deficits during the postpsychotic stages of schizophrenia. A replication and extension.

Authors:  R F Asarnow; D J MacCrimmon
Journal:  Arch Gen Psychiatry       Date:  1981-09

Review 6.  Information processing and attention dysfunctions in schizophrenia.

Authors:  D L Braff
Journal:  Schizophr Bull       Date:  1993       Impact factor: 9.306

7.  Eye tracking impairment in clinically identified patients with schizotypal personality disorder.

Authors:  L J Siever; R Keefe; D P Bernstein; E F Coccaro; H M Klar; Z Zemishlany; A E Peterson; M Davidson; T Mahon; T Horvath
Journal:  Am J Psychiatry       Date:  1990-06       Impact factor: 18.112

8.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06

9.  Visual sustained attention: image degradation produces rapid sensitivity decrement over time.

Authors:  K H Nuechterlein; R Parasuraman; Q Jiang
Journal:  Science       Date:  1983-04-15       Impact factor: 47.728

10.  Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress.

Authors:  K H Nuechterlein; M E Dawson; M Gitlin; J Ventura; M J Goldstein; K S Snyder; C M Yee; J Mintz
Journal:  Schizophr Bull       Date:  1992       Impact factor: 9.306

View more
  4 in total

1.  Temporal lobe thickness and verbal memory in first-degree relatives of individuals with schizophrenia.

Authors:  Vindia G Fernandez; Robert Asarnow; Katherine L Narr; Kenneth L Subotnik; Heidi Kuppinger; David Fogelson; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2018-02-28       Impact factor: 4.939

2.  Mean diffusivity and fractional anisotropy as indicators of disease and genetic liability to schizophrenia.

Authors:  Kristi A Clark; Keith H Nuechterlein; Robert F Asarnow; Liberty S Hamilton; Owen R Phillips; Nathan S Hageman; Roger P Woods; Jeffry R Alger; Arthur W Toga; Katherine L Narr
Journal:  J Psychiatr Res       Date:  2011-02-08       Impact factor: 4.791

3.  Longitudinal associations between social anxiety disorder and avoidant personality disorder: A twin study.

Authors:  Fartein Ask Torvik; Audun Welander-Vatn; Eivind Ystrom; Gun Peggy Knudsen; Nikolai Czajkowski; Kenneth S Kendler; Ted Reichborn-Kjennerud
Journal:  J Abnorm Psychol       Date:  2015-11-16

4.  Design of a multicentered randomized controlled trial on the clinical and cost effectiveness of schema therapy for personality disorders.

Authors:  Lotte L M Bamelis; Silvia M A A Evers; Arnoud Arntz
Journal:  BMC Public Health       Date:  2012-01-24       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.